Could 2026’s "AI-driven dosage" finally eliminate the risks of over-stimulation during labor?
One of the biggest breakthroughs in the 2026 obstetric landscape is the use of Artificial Intelligence to monitor and adjust the administration of the oxytocin injection market in real-time. Historically, induction of labor required manual adjustments based on periodic observations, but today’s "smart-infusion" pumps are connected to continuous fetal and maternal monitors. In 2026, the AI...
0 Comentários 0 Compartilhamentos 43 Visualizações 0 Anterior